Skip to main content

Published locations for Metastatic CRC: Aflibercept-FOLFIRI is a feasible second-line treatment option

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Metastatic CRC: Aflibercept-FOLFIRI is a feasible second-line treatment option

User login

  • Reset your password
  • /content/metastatic-crc-aflibercept-folfiri-feasible-second-line-treatment-option
  • /hematology-oncology/article/244824/gastrointestinal-cancer/metastatic-crc-aflibercept-folfiri